Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 10, 2006. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
The material change reported is the acquisition of Ordinary Shares by two individuals on July 6, 2006, under a Single Company ISA at a price of GBP 15.29 per share:
- Mr. J Heslop: Acquired 4 shares.
- Mr. A Witty: Acquired 3 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly details the transaction notification in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: July 6, 2006.
- Share Price: GBP 15.29 per Ordinary Share.
- Participants: Mr. J Heslop and Mr. A Witty.
- Transaction Type: Purchase via Single Company ISA.
- Notification Date: July 10, 2006.